0000950170-24-001195.txt : 20240103
0000950170-24-001195.hdr.sgml : 20240103
20240103173050
ACCESSION NUMBER: 0000950170-24-001195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hogue Dale Curtis Jr.
CENTRAL INDEX KEY: 0002006649
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33038
FILM NUMBER: 24508338
MAIL ADDRESS:
STREET 1: C/O ALAUNOS THERAPEUTICS, INC.
STREET 2: 2617 BISSONNET ST, SUITE 225
CITY: HOUSTON
STATE: TX
ZIP: 77005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001107421
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841475642
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2617 BISSONNET ST
STREET 2: SUITE 225
CITY: HOUSTON
STATE: TX
ZIP: 77005
BUSINESS PHONE: (346) 355-4099
MAIL ADDRESS:
STREET 1: 2617 BISSONNET ST
STREET 2: SUITE 225
CITY: HOUSTON
STATE: TX
ZIP: 77005
FORMER COMPANY:
FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC
DATE OF NAME CHANGE: 20050919
FORMER COMPANY:
FORMER CONFORMED NAME: EASYWEB INC
DATE OF NAME CHANGE: 20010213
4
1
ownership.xml
4
X0508
4
2023-12-29
0001107421
Alaunos Therapeutics, Inc.
TCRT
0002006649
Hogue Dale Curtis Jr.
C/O ALAUNOS THERAPEUTICS, INC.
2617 BISSONNET ST, SUITE 225
HOUSTON
TX
770005
true
false
false
false
false
Employee Stock Option (right to buy)
0.071
2023-12-29
4
A
false
150000
0.00
A
2033-12-28
Common Stock
150000
150000
D
Employee Stock Option (right to buy)
0.071
2023-12-29
4
A
false
41667
0.00
A
2033-12-28
Common Stock
41667
41667
D
One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.
In five equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date.
/s/ Michael Wong, By PoA from Dale Curtis Hogue, Jr.
2024-01-03